<Record>
<Term>Leukotriene Antagonists</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Hormone Antagonists</ParentTerm>
<ClassificationPath>Hormones, Hormone Substitutes, and Hormone Antagonists/Hormone Antagonists/Leukotriene Antagonists</ClassificationPath>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Physiological Effects of Drugs/Hormones, Hormone Substitutes, and Hormone Antagonists/Hormone Antagonists/Leukotriene Antagonists</ClassificationPath>
<BroaderTerm>Pharmacologic Actions</BroaderTerm>
<BroaderTerm>Leukotriene Antagonists</BroaderTerm>
<BroaderTerm>Hormone Antagonists</BroaderTerm>
<BroaderTerm>Chemical Actions and Uses</BroaderTerm>
<BroaderTerm>Hormones, Hormone Substitutes, and Hormone Antagonists</BroaderTerm>
<BroaderTerm>Physiological Effects of Drugs</BroaderTerm>
<Synonym>Leukotriene Antagonists</Synonym>
<Synonym>Leukotriene Receptor Antagonists</Synonym>
<Description>A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level.</Description>
<Source>MeSH</Source>
</Record>
